Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
selisistat (SEN-196)
i
Other names:
SEN-196, SEN196, SEN 0014196, EX-527
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
AOP Orphan Pharma
Drug class:
SIRT1 inhibitor
‹
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Colorectal Cancer
TP53 mutation
Colorectal Cancer
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
KRAS mutation
Lung Cancer
KRAS mutation
Lung Cancer
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
SEN-196
Sensitive: D – Preclinical
SEN-196
Sensitive
:
D
KRAS mutation
Lung Cancer
KRAS mutation
Lung Cancer
erlotinib + SEN-196
Sensitive: D – Preclinical
erlotinib + SEN-196
Sensitive
:
D
erlotinib + SEN-196
Sensitive: D – Preclinical
erlotinib + SEN-196
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.